Canada Sets Jan 2019 Deadline For Mandatory Adoption Of MDSAP Within Medtech Framework
This article was originally published in SRA
Executive Summary
As of January 2017, medical device manufacturers selling their products in Canada will get two years to comply with the requirements of the Medical Device Single Audit Program. Specifically, after January 2019 MDSAP will become the sole mechanism to demonstrate compliance with Canadian quality management system requirements1.
You may also be interested in...
Canada's Switch From CMDCAS To MDSAP Went Off Without A Hitch – Despite 403 Firms Leaving The Market
It's been one full month since the Medical Device Single Audit Program officially replaced the traditional Canadian Medical Devices Conformity Assessment System (CMDCAS) audits, and Health Canada is claiming success. Although 403 device-makers withdrew from the Canadian market because of the switch to MDSAP, it's nothing to be concerned about, a Health Canada spokesperson says.
India Proposes Tiered Approach To Oversee Genome Editing
India has proposed three categories for grouping genetically edited organisms based on the complexity of modifications.
UK's MHRA Looks Beyond Brexit Transition Period
Now that the UK has left the EU, the UK’s medicines regulator says it will use the rest of this year to work out how best to ensure continuity of drug regulation after the Brexit transition period ends on 31 December.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: